Bd announces 510(k) clearance of pristine™ long-term hemodialysis catheter

Franklin lakes, n.j., april 14, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced it has received 510(k) clearance from the u.s. food and drug administration (fda) for the pristine™ long-term hemodialysis catheter, a new hemodialysis catheter with a unique side-hole free symmetric y-tip™ distal lumen design.
BDX Ratings Summary
BDX Quant Ranking